Skip to main content
Log in

Hepatic coma

Presentation and discussion of case

  • Medical Grand Rounds
  • Published:
The American Journal of Digestive Diseases Aims and scope Submit manuscript

Summary

The neurologic symptoms accompanying severe liver disease have been termed hepatic coma. This syndrome is characterized by personality changes, inappropriate behavior, stupor, and eventually coma. The peculiar flapping tremor is the most characteristic physical finding. Abnormalities of the electroencephalogram have been correlated with the depth of coma. The neuropathologic changes accompanying hepatic coma are limited to a diffuse protoplasmic astrocytosis.

The most frequent biochemical abnormality is an elevation of the blood ammonia. This results from the breakdown of nitrogenous products in the bowel which reach the brain in toxic quantities as the result of portal venous collateral circulation around the liver and/or as the result of defective liver function.

Treatment is directed toward improving liver function and removing the toxic breakdown products of gastrointestinal hemorrhage from the bowel. Administration of sodium glutamate has been used with variable results. Similar observations have been reported concerning the value of adrenal steroid therapy and administration of oral antibiotics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adams, R. D., andFoley, J. M. The neurological disorder associated with liver disease.Proc. A. Res. Nerv. & Ment. Dis. 32:198, 1953.

    Google Scholar 

  2. Alexander, J. W., andPorter, C. E. The treatment of a patient in hepatic coma with intravenous sodium glutamate and ACTH.Gastroenterology 26:926, 1953.

    Google Scholar 

  3. Alexander, R. W., Berman, E., andBalfour, D. C., Jr. Relationship of glutamic acid and blood ammonium to hepatic coma.Gastroenterology 29:711, 1955.

    PubMed  Google Scholar 

  4. Amatuzio, D. S., andNesbitt, S. A study of pyruvic acid in the blood and spinal fluid of patients with liver disease with and without hepatic coma.J. Clin. Invest. 29:1486, 1950.

    PubMed  Google Scholar 

  5. Amatuzio, D. S.,et al. A study of serum electrolytes (Na, K, Ca, P) in patients with severely decompensated portal cirrhosis of the liver.J. Lab. & Clin. Med. 39:26, 1952.

    Google Scholar 

  6. Amatuzio, D. S., Weber, L. J., andNesbitt, S. Bilirubin and protein in the cerebrospinal fluid of jaundiced patients with severe liver disease with and without coma.J. Lab. & Clin. Med. 41:615, 1953.

    Google Scholar 

  7. Benhamou, J. P., Hartmann, L., andFauvert, R. Transitory hepatic coma: I. Clinical study.Presse méd. 63:1451, 1955.

    Google Scholar 

  8. Bessman, S. P. “Ammonia Metabolism in Animals.” InMcElroy, W. D., andGlass, B. (Eds.):Inorganic Nitrogen Metabolism. Baltimore, Johns Hopkins Press, 1956.

    Google Scholar 

  9. Bessman, S. P. The role of ammonia in clinical syndromes.Ann. Int. Med. 44:1037, 1956.

    PubMed  Google Scholar 

  10. Bessman, S. P., andBessman, A. N. The cerebral and peripheral uptake of ammonia in liver disease with an hypothesis for the mechanism of hepatic coma.J. Clin. Invest. 34:622, 1955.

    PubMed  Google Scholar 

  11. Bessman, S. P., andBradley, J. M. Uptake of ammonia by muscle.New England J. Med. 253:1143, 1955.

    Google Scholar 

  12. Bessman, S. P., Fazekas, J. F., andBessman, A. N. Uptake of ammonia by the brain in hepatic coma.Proc. Soc. Exper. Biol. & Med. 85:66, 1954.

    Google Scholar 

  13. Bickford, R. G., andButt, H. R. Hepatic coma: The electroencephalographie pattern.J. Clin. Invest. 34:790, 1955.

    PubMed  Google Scholar 

  14. Butt, H. R. Panel discussion: The clinical and biochemical features of hepatic insufficiency.Gastroenterology 25:471, 1953.

    PubMed  Google Scholar 

  15. Butt, H. R., andMason, H. L. Fetor hepaticus: Its clinical significance and attempts at chemical isolation.Gastroenterology 26:829, 1954.

    PubMed  Google Scholar 

  16. Carfagno, S. C.,et al. Hepatic coma: A clinical, laboratory and pathological study.New England J. Med. 249:303, 1953.

    Google Scholar 

  17. Chalmers, T. C.,et al. The effects of intravenous sodium glutamate on blood “ammonia,” ketoacids and amino acids in patients with hepatic coma.J. Clin. Invest. 34:926, 1955.

    Google Scholar 

  18. Davidson, C. S. Cirrhosis of the liver.Am. J. Med. 16:863, 1954.

    PubMed  Google Scholar 

  19. Davidson, C. S. Cirrhosis of the liver treated with prolonged sodium restrictions.J.A.M.A. 159:1257, 1955.

    Google Scholar 

  20. Davidson, C. S. “Hepatic Coma.” InDock, W., andSnapper, I. (Eds.):Advances in Internal Medicine. Chicago, Yr. Bk. Pub. 1955, Vol. VII, pp. 33–63.

    Google Scholar 

  21. Davidson, C. S. “Hepatic Coma.” InSchiff, L. (Ed.):Diseases of the Liver. Philadelphia, Lippincott, 1956.

    Google Scholar 

  22. Ducci, H. Cortisone in hepatitis: Recovery in five comatose cases.Merck Rep. 62:213, 1953.

    Google Scholar 

  23. Eberling, W. C.,et al. Management of patients with portal hypertension undergoing venous-shunt surgery.New England J. Med. 254:141, 1956.

    Google Scholar 

  24. Evans, A. S., Spring, H., andNelson, R. S. Adrenal hormone therapy in viral hepatitis: III. The effect of ACTH and cortisone in severe and fulminant cases.Ann. Int. Med. 38:1148, 1953.

    PubMed  Google Scholar 

  25. Farquhar, J. D.,et al. Studies on the use of Aureomycin in hepatic disease: III. A note on Aureomycin therapy in hepatic coma.Am. J. M. Sc. 220:166, 1950.

    PubMed  Google Scholar 

  26. Foley, J. M., Watson, C. W., andAdams, R. D. Significance of the electroencephalographic changes in hepatic coma.Tr. Am. Neurol. A. 75:161, 1950.

    Google Scholar 

  27. Foulk, W. T.,et al. Hepatic coma: A clinical and pathologic study.Gastroenterology 29:171, 1955.

    PubMed  Google Scholar 

  28. Frerichs, F. T. A Clinical Treatise on Diseases of the Liver. Translated by C. Murchison. London, New Sydenham Society, 1860, Vol. I, p. 241.

    Google Scholar 

  29. Fuld, H. Uber die diagnostische Verwertbarkeit von Ammoniakbestimmungen im Blut.Klin. Wchnschr. 12:1364, 1933.

    Google Scholar 

  30. Gabuzda, G. J., Jr., Traeger, H. S., andDavidson, C. S. Effects of sodium chloride administration and restriction and of abdominal paracentesis on electrolyte and water balance.J. Clin. Invest. 33:780, 1954.

    PubMed  Google Scholar 

  31. Havens, L. L., andChild, C. G. Recurrent psychosis associated with liver disease and elevated blood ammonia.New England J. Med. 252:756, 1955.

    Google Scholar 

  32. Jones, C. M. The role of experimental medicine in our understanding of the function of the liver in health and disease.Proc. Staff Meet. Mayo Clin. 27:553, 1952.

    Google Scholar 

  33. Kirk, E. Amino-acid and ammonia metabolism in liver diseases.Acta med. scand. (Suppl.)77:1, 1936.

    Google Scholar 

  34. Karl, M. M.,et al. Liver coma, with particular reference to management.Arch. Int. Med. 91:159, 1953.

    Google Scholar 

  35. McDermott, W. V., Jr., andAdams, R. D. Episodic stupor associated with an Eck fistula in the human with particular reference to the metabolism of ammonia.J. Clin. Invest. 33:1, 1954.

    PubMed  Google Scholar 

  36. McDermott, W. V., Adams, R. D., andRiddell, A. G. Ammonia levels in blood and cerebrospinal fluid.Proc. Soc. Exper. Biol. & Med. 88:380, 1955.

    Google Scholar 

  37. McDermott, W. V., Jr., Warsham, J., andRiddell, A. G. Treatment of “hepatic coma” withl-glutamic acid.New England J. Med. 253:1093, 1955.

    Google Scholar 

  38. Murphy, T. L.,et al. Hepatic coma: Clinical and laboratory observations on fatty patients.New England J. Med. 239:605, 1948.

    Google Scholar 

  39. Nesbitt, S. Excretion of coproporphyrin in hepatic disease: III. Urinary excretion of coproporphyrin in hepatic insufficiency during episodes characterized by neurologic manifestations.Arch. Int. Med. 71:62, 1953.

    Google Scholar 

  40. Phear, E., Sherlock, S., andSummerskill, W. H. J. Blood ammonium levels in liver disease and hepatic coma.Lancet 268:836, 1955.

    PubMed  Google Scholar 

  41. Phillips, G. B.,et al. The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances.New England J. Med. 247:239, 1951.

    Google Scholar 

  42. Riddell, A. G., Kopple, P. N., andMcDermott, W. V., Jr. Etiology of “meat intoxication” in Eck fistula dog.Surgery 36:675, 1954.

    PubMed  Google Scholar 

  43. Sborov, V. M.,et al. The clinical usefulness of ACTH and cortisone in liver disease.Gastroenterolgy 28:745, 1955.

    Google Scholar 

  44. Schwartz, R.,et al. Dietary protein in the genesis of hepatic coma.New England J. Med. 251:685, 1954.

    Google Scholar 

  45. Seegmiller, J. E., Schwartz, R., andDavidson, C. S. The plasma “ammonia” and glutamine content in patients with hepatic coma.J. Clin. Invest. 33:984, 1954.

    PubMed  Google Scholar 

  46. Seligson, D., McCormick, G. J., andSborov, V. Blood ketoglutarate and pyruvate in liver disease.J. Clin. Invest. 31:661, 1952.

    Google Scholar 

  47. Sessions, J. T., Jr.,et al. The effect of barbiturates in patients with liver disease.J. Clin. Invest. 33:1116, 1954.

    PubMed  Google Scholar 

  48. Sherlock, S. Diseases of the Liver and Biliary System. Springfield, Ill., Thomas, 1955, pp. 96–110.

    Google Scholar 

  49. Sherlock, S. Treatment of hepatic coma.Gastroenterologia 85:241, 1956.

    PubMed  Google Scholar 

  50. Sherlock, S.,et al. Portal-systemic encephalopathy: Neurological complications of liver disease.Lancet 2:453, 1954.

    Google Scholar 

  51. Snell, A. M., andButt, H. R. Hepatic coma: Observations bearing on its nature and treatment.Tr. A. Am. Physicians 56:321, 1941.

    Google Scholar 

  52. Traeger, H. S.,et al. Blood “ammonia” concentration in liver disease and liver coma.Metabolism 3:99, 1954.

    PubMed  Google Scholar 

  53. Waelsch, H.,et al. Glutamic acid antimetabolites: The sulfoxide derived from methionine.J. Biol. Chem. 166:273, 1946.

    Google Scholar 

  54. Walshe, J. M. Observation on the symptomatology and pathogenesis of hepatic coma.Quart. J. Med. 20:421, 1951.

    PubMed  Google Scholar 

  55. Walshe, J. M. Glutamic acid in hepatic coma.Lancet 268:1235, 1955.

    PubMed  Google Scholar 

  56. Walshe, J. M. The effect of glutamic acid on the coma of hepatic failure.Lancet 1:1075, 1953.

    PubMed  Google Scholar 

  57. Webster, L. T., Jr. The production of impending hepatic coma in alcoholics with cirrhosis by a carbonic anhydrase inhibitor (Diamox).J. Clin. Invest. 34:969, 1955.

    Google Scholar 

  58. Webster, L. T., Jr., andDavidson, C. S. Hepatic coma: Effect of sodium glutamate.J. Clin. Invest. 33:971, 1954.

    Google Scholar 

  59. Welch, C. S.,et al. Treatment of bleeding from portal hypertension in patients with cirrhosis of the liver.New England J. Med. 254:493–502, 1956.

    Google Scholar 

  60. Weil-Malherbe, H. Studies on brain metabolism: I. The metabolism of glutamic acid in brain.Biochem. J. 30:665, 1936.

    Google Scholar 

  61. White, L. P.,et al. Ammonium tolerance in liver disease: Observations based on catheterization of the hepatic veins.J. Clin. Invest. 34:158, 1955.

    PubMed  Google Scholar 

  62. Wu, C., Bollman, J. L., andButt, H. R. Changes in free amino acids in the plasma during hepatic coma.J. Clin. Invest. 34:845, 1955.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clinton Texter, E., Borden, C.W. Hepatic coma. Digest Dis Sci 3, 159–177 (1958). https://doi.org/10.1007/BF02232388

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02232388

Keywords

Navigation